{
  "context": {
    "rules": [
      "Rule1: If ResearcherB identifies a compound in PlantC, then CompanyA does not terminate research on DrugX.",
      "Rule2: If ResearcherB synthesizes DrugX, then ResearcherB tests DrugX in vitro.",
      "Rule3: ResearcherB synthesizes DrugX or ResearcherB isolates a compound from PlantC.",
      "Rule4: If ResearcherB isolates a compound from PlantC, then DrugX treats DiseaseY.",
      "Rule5: If ResearcherB tests DrugX in vitro, then DrugX treats DiseaseY.",
      "Rule6: If ResearcherB receives funding from GrantD, then DrugX treats DiseaseY.",
      "Rule7: If ResearcherB receives funding from GrantE, then DrugX treats DiseaseY.",
      "Rule8: If CompanyA licenses the compound from ResearcherB, then CompanyA files a patent for DrugX.",
      "Rule9: CompanyA requests expedited review from the FDA or CompanyA submits additional data to the FDA.",
      "Rule10: If CompanyA submits additional data to the FDA, then if DrugX does not treat DiseaseY, CompanyA submits an application to the FDA.",
      "Rule11: If CompanyA initiates a lawsuit against the FDA, then CompanyA wins the case.",
      "Rule12: CompanyA initiates a lawsuit against the FDA or CompanyA appeals the FDA's decision or if CompanyA requests expedited review from the FDA, then if DrugX does not treat DiseaseY, CompanyA submits an application to the FDA.",
      "Rule13: The FDA issues approval for DrugX or the FDA extends the review period or the FDA consults external reviewers or if DrugX does not treat DiseaseY, then CompanyA submits an application to the FDA.",
      "Rule14: The FDA issues rejection for DrugX or the FDA does not issue approval for DrugX.",
      "Rule15: If ConferenceF invites ResearcherB as a speaker, then ResearcherB presents findings at ConferenceF or if ResearcherB synthesizes DrugX, then DrugX treats DiseaseY.",
      "Rule16: ConferenceF invites ResearcherB as a speaker or ResearcherB accepts the invitation from ConferenceF.",
      "Rule17: If ResearcherB accepts the invitation from ConferenceF, then ResearcherB presents findings at ConferenceF or if ResearcherB synthesizes DrugX, then DrugX treats DiseaseY.",
      "Rule18: If DrugX cures DiseaseY, then DrugX passes clinical trial.",
      "Rule19: If DrugX reduces symptoms of DiseaseY, then if DrugX does not treat DiseaseY, then DrugX receives approval from the FDA.",
      "Rule20: If CompanyA recalls DrugX from the market, then CompanyA halts production of DrugX.",
      "Rule21: If CompanyA submits an application to the FDA, then StudyZ publishes results.",
      "Rule22: If ResearcherB does not receive funding from GrantD and ResearcherB does not receive funding from GrantE, then CompanyA licenses the compound from ResearcherB.",
      "Rule23: If DrugX does not cure DiseaseY and DrugX does not reduce symptoms of DiseaseY, then CompanyA recalls DrugX from the market.",
      "Rule24: If it is not the case that if DrugX does not treat DiseaseY then CompanyA submits an application to the FDA, then CompanyA terminates research on DrugX.",
      "Rule25: If DrugX does not treat DiseaseY, then DrugX does not receive approval from the FDA."
    ],
    "facts": [
      "Fact1: ResearcherB identifies a compound in PlantC.",
      "Fact2: CompanyA does not file a patent for DrugX.",
      "Fact3: DrugX does not pass clinical trial.",
      "Fact4: CompanyA does not appeal the FDA's decision.",
      "Fact5: CompanyA does not win the case.",
      "Fact6: The FDA does not consult external reviewers.",
      "Fact7: The FDA does not extend the review period.",
      "Fact8: The FDA does not issue rejection for DrugX.",
      "Fact9: ResearcherB does not present findings at ConferenceF.",
      "Fact10: CompanyA does not halt production of DrugX.",
      "Fact11: StudyZ does not publish results."
    ]
  },
  "question": "DrugX treats DiseaseY."
}